This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Shanghai Daidai Investment Consulting Co., Ltd. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Quanlin An
Introduction
Quanlin An is a notable inventor based in Shanghai, China. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on pyrazolo[1,5-a]pyridine derivatives. His research focuses on the preparation methods and medical applications of these compounds.
Latest Patents
Quanlin An holds a patent for "Pyrazolo[1,5-a]pyridine derivatives, preparation method therefor and use thereof." This patent describes a pyrazolo[1,5-a]pyridine derivative, along with its preparation method and potential medical uses. The derivative is particularly noted for its application as a rearranged during transfection (RET) inhibitor, which could have therapeutic implications.
Career Highlights
An is currently associated with Shanghai Daidai Investment Consulting Co., Ltd. His work at this company has allowed him to explore various aspects of medicinal chemistry and contribute to the development of new therapeutic agents.
Collaborations
Quanlin An has collaborated with notable colleagues, including Zhongli Wang and Jianping Zhang. These partnerships have enhanced his research and expanded the scope of his innovations.
Conclusion
Quanlin An's contributions to the field of medicinal chemistry, particularly through his patented work on pyrazolo[1,5-a]pyridine derivatives, highlight his role as an influential inventor. His ongoing research and collaborations continue to pave the way for advancements in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile